1. Findlay JM, Nisar J, Darsaut T. Cerebral vasospasm. A Review. Can J Neurol Sci 2016; 43: 15-32.
2. Tomassoni D, Lanari A, Silvestrelli G.: Traini E, Amenta F. Nimodipine and its use in cerebrovascular disease: Evidence from recent preclinical and controlled clinical studies. Clin Exp Hypertens 2007; 30: 744-766.
3. Birks J, López‐Arrieta J. Nimodipine for primary degenerative, mixed and vascular dementia. Cochrane Db Syst Rev 2002, CD000147.
4. Scheller K, Scheller C. Nimodipine promotes regeneration of peripheral facial nerve function after traumatic injury following maxillofacial surgery: An off label pilot-study. J Cranio Maxill Surg 2012; 40: 427-434.
5. Mattsson P, Janson AM, Aldskogius H, Svensson M. Nimodipine promotes regeneration and functional recovery after intracranial facial nerve crush. J Comp Neurol 2001; 437: 106-117.
6. Lecht S, Rotfeld E, Arien-Zakay H, Tabakman R, Matzner H, et al. Neuroprotective effects of nimodipine and nifedipine in the NGF-differentiated PC12 cells exposed to oxygen-glucose deprivation or trophic withdrawal. Int J Dev Neurosci 2012; 30: 465-469.
7. Luiten PG, Kdouma BR, AVan der Zee E. Neuroprotection against NMDA induced cell death in rat nucleus basalis by Ca2+ antagonist nimodipine, influence of aging and developmental drug treatment. Neurodegeneration 1995; 4: 307-314.
8. Li H, Yang X, Shi W, Ma Z, Feng G, Wang Q, Shen L, Xie C. Protective effects of nimodipine on cerebrovascular function in chronic alcoholic encephalopathy. Int J Mol Med 2014; 33: 201-208.
9. Jordan M, Blake AB, Hutsell M, Newland C. Dietary nimodipine delays the onset of methylmercury neurotoxicity in mice. Neurotoxicology 2013; 37: 108-117.
10. Bork K, Wurm F, Haller H, Strauss C, Scheller C, Gnanapragassam VS, Horstkorte R. Neuroprotective and neuroregenerative effects of nimodipine in a model system of neuronal differentiation and neurite outgrowth. Molecules 2015; 20, 1003-1013.
11. Dispersyn G, Nuydens R, Borgers M, Geerts H. Nimodipine and flunarizine have different effects on survival and morphology of PC12 cells during nerve growth factor deprivation. Eur J Pharmacol 1999; 384: 61-70.
12. Ju L, Zhang X, Zhang T, Zheng J. Research on recovery function of two drugs combination on rat sciatic nerve injury regeneration model. Pak J Pharm Sci 2014; 27: 1695–1698.
13. Nishimoto K, Kumai Y, Sanuki T, Minoda R, Yumoto E. The impact of nimodipine administration combined with nerve-muscle pedicle implantation on long-term denervated rat thyroarytenoid muscle. Laryngoscope 2013; 123: 952–959.
14. Facchinetti F, Fasolato C, Giudice ED, Burgo A, Furegato S, Fusco M, et al. Nimodipine selectively stimulated β-amyloid 1–42 secretion by a mechanism independent of calcium influx blockage. Neurobiol Aging 2006; 27: 218-227.
15. Li Y, Hu X, Liu Y, Bao Y, An L. Nimodipine protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation. Neuropharmacology 2009; 56: 580-589.
16. Kariya T, Takahashi K, Itagaki D, Hasegawa Y. Scallop mantle extract inhibits insulin signaling in HepG2 cells. Food Sci Nutr 2019; 7, 2159-2166.
17. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227; 680-685.
18. Shmueli O, Gdalyahu A, Sorokina K, Nevo E, Avivi A, Reiner O. DCX in PC12 cells: CREB-mediated transcription and neurite outgrowth. Hum Mol Genet 2001; 10: 1061–1070.
19. Lai HC, Wu MJ, Chen PY, Sheu TT, Chiu SP, Lin MH, et al. Neurotrophic effect of citrus 5-hydroxy-3,6,7,8,3′,4′-hexamethoxyflavone: Promotion of neurite outgrowth via cAMP/PKA/CREB pathway in PC12 cells. PLoS One 2011; 6: e28280.
20. Williams CM, Mohse MA, Vauzou, D, Rendeiro C, Butler LT, Ellis JA, et al. Blueberry-induced changes in spatial working memory correlate with changes in hippocampal CREB phosphorylation and brain-derived neurotrophic factor (BDNF) levels. Free Radical Biol Med 2008; 45: 295-305.
21. Seitz C, Causlin M, Heath V, Colangelo AM, Malik R, Lee S, et al. CAAT/Enhancer-binding protein δ and cAMP-response element-binding protein mediate inducible expression of the nerve growth factor gene in the central nervous system. J Biol Chem 2006; 281: 17681-17688.
22. Barnett M, Hall S, Dixit M, Arany I. Simvastatin attenuates oleic acid-induced oxidative stress through CREB-dependent induction of heme oxygenase-1 in renal proximal tubule cells. Pediatr Res 2016; 79: 243–250.
23. Walton MR, Dragunow M. Is CREB a key to neuronal survival? Trends Neurosci 2000; 23: 48-53.
24. Finkbeiner S. CREB couples neurotrophin signals to survival messages. Neuron 2000; 25: 11-14.
25. Sygnecka K, Heine H, Scherf N, Fasold M, Binder H, Scheller C, Franke H. Nimodipine enhances neurite outgrowth in dopaminergic brain slice co-cultures. Int J Dev Neurosci 2015; 40: 1-11.
26. Koskimäki J, Matsui N, Umemori J, Rantamäki T, Castrén E. Nimodipine activates TrkB neurotrophin receptors and induces neuroplastic and neuroprotective signaling events in the mouse hippocampus and prefrontal cortex. Cell Mol Neurobiol 2015; 35: 189–196.
27. Hu M, Liu Z, Lv P, Wang H, Zhu Y, Qi Q, Xu J. Autophagy and Akt/CREB signalling play an important role in the neuroprotective effect of nimodipine in a rat model of vascular dementia. Behav Brain Res 2017; 325: 79-86.
28. Zhang L, Zhao H, Zhang X, Chen L, Zhao X, Bai X, Zhang J. Nobiletin protects against cerebral ischemia via activating the p-Akt, p-CREB, BDNF and Bcl-2 pathway and ameliorating BBB permeability in rat. Brain Res Bull 2013; 96: 45-53.
29. Yoo JM, Lee BD, Sok DE, Ma JY, Kim MR. Neuroprotective action of N-acetyl serotonin in oxidative stress-induced apoptosis through the activation of both TrkB/CREB/BDNF pathway and Akt/Nrf2/Anti-oxidant enzyme in neuronal cells. Redox Biology 2017; 11: 592-599.
30. Zhang X, Odom DT, Koo SH, Conkright MD, Canettieri G, Best J, et al. Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci USA 2005; 102:4459-4464.
31. Buwalda B, Naber R, Nyakas C, Luiten PGM. Nimodipine accelerates the postnatal development of parvalbumin and S-100β immunoreactivity in the rat brain. Dev Brain Res 1994; 78: 210-216.
32. Singh A, Verma P, Raju A, Mohanakumar KP. Nimodipine attenuates the parkinsonian neurotoxin, MPTP-induced changes in the calcium binding proteins, calpain and calbindin. J Chem Neuroanat 2019; 95: 89-94.
33. Nascimento SV, D’alva MS, Oliveira AA, Freitas MF, Vasconcelos SMM, Sousa FCF, Fonteles MMF. Anti-oxidant effect of nimodipine in young rats after pilocarpine-induced seizures. Pharmacol Biochem Behav 2005; 82: 11-16.
34. Janis RA, Silve PJ, Triggle DJ. Drug action and cellular calcium regulation. Adv Drug Res 1987; 16: 309-591.
35. Peroutka SJ, Allen GS. Calcium channel antagonist binding sites labeled by 3H-nimodipine in human brain. J Neurosurg 1983; 59: 933-937.
)